News
Dow, S&P 500, and Nasdaq 100 futures are rising in premarket trading ahead of the Jobs Report for June. Stock markets are watching developments on U.S. trade deals and Trump's tax and spending bill, ...
Stocks were headed for gains early Thursday ahead of jobs numbers that could give the market a better sense of how the U.S. economy is faring. Futures tracking the Dow Jones Industrial Average climbed ...
The U.S. economy lost private sector jobs in June, the first time hiring had contracted since March 2023, according to ...
2h
Vietnam Investment Review on MSNOcta explains crypto CFDs Trade crypto without owning itKUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 3 July 2025 - Crypto volatility poses both potentially spectacular possibilities and enormous risks. For example, by investing in crypto assets on ...
3h
Capital Market on MSNWall Street Rallies on U.S.-Vietnam Trade Deal; Nasdaq and S&P Surge, Steel Stocks SoarThe tech-heavy Nasdaq jumped 190.24 points or 0.9% to 20,393.13 and the S&P 500 climbed 29.41 points or 0.5% to 6,227.42, ...
3h
NDTV Profit on MSNStock Market Live: Sensex Rises Nearly 300 Points; Nifty Rises Over 80 Points As ICICI Bank LeadsThe S&P 500 and Dow Jones Industrial Average were trading 0.04% and 0.03% higher, respectively. The Nasdaq 100 future was ...
EverCommerce earns a 'Hold' as restructuring limits near-term upside and I see no compelling bargain at these levels. Read ...
5h
Investor's Business Daily on MSNDow Jones Futures: S&P 500 Hits High On Vietnam Trade Deal; Nike, Tesla, Oracle RallyDow Jones futures were little changed overnight, along with S&P 500 futures and Nasdaq futures. The June jobs report is on ...
5h
NDTV Profit on MSNStock Market Today: All You Need To Know Going Into Trade On July 3The weekly futures contract for the Nifty will expire today.US stock futures held steady on Wednesday evening after the S&P ...
Bell Potter has good things to say about this high-flying stock. The post Buy this ASX 200 share that is having a 'milestone year' appeared first on The Motley Fool Australia.
Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results